Medical specialists often order a multiparametric MRI (mpMRI) following elevated PSA levels to determine if biopsies are ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Dermot Murnaghan has said he ‘fell through the gaps’ before getting his cancer diagnosis. The former Sky News presenter, 67, ...

Immuron shares this morning surged more than 30% after the company reported robust sales of its traveller's trots prophylactic, Travelan.

Former Minister of Health, Dr Bernard Okoe Boye, has urged men aged 30 years and above to prioritise their health by undergoing seven key medical tests to detect some life-threatening conditions early ...

Let's find out what is getting investors excited today. The post Guess which ASX 200 stock just jumped 9% on big news appeared first on The Motley Fool Australia.

Shares in Clarity Pharmaceuticals soared in early trading after the biotech company announced it has completed recruitment ...

Johnson & Johnson ( NYSE: JNJ) Q2 2025 Earnings Conference Call July 16, 2025 8:30 AM ET ...

Clarity Pharmaceuticals (ASX: CU6), a clinical-stage radiopharmaceutical company focused on developing next-generation products to improve cancer treatment outcomes, has announced the successful ...